Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Johnson & Johnson — Janssen Pharmaceuticals
Entity

Johnson & Johnson — Janssen Pharmaceuticals

Tracked across 2 events · 12 articles · First seen May 19, 2026 · Last active May 28, 2026

Sentiment
0
Attention
3
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
2 0
Business
Protagonist Therapeutics CEO Attends Conferences
AnBogen Therapeutics announced that its President and CEO, Dinesh V. Patel, Ph.D., will participate in two investment bank conferences in June 2026: the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global…
Impact: Johnson & Johnson — Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, is responsible for the further development and commercialization of ICOTYDE.
May 28, 2026 · 6 articles
3 0
Business
Anaveon Appoints Zanelli, Jene
Impact: Assertio Therapeutics>>> acquired Nucynta from Johnson & Johnson — Janssen Pharmaceuticals>>>.
May 19, 2026 · 6 articles
Key Actions (1)
50 Johnson & Johnson — Janssen Pharmaceuticals licensed drug AnBogen TherapeuticsProtagonist Therapeutics...
NEWSDESK
Track Johnson & Johnson — Janssen Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.